RECENT APPROACHES IN GLUCOSE RESPONSIVE INSULIN DELIVERY SYSTEM
DOI:
https://doi.org/10.22159/ajpcr.2022.v15i2.43572Keywords:
Gluconic acid, Phenyl boronic acid, Concanavalin A, Hydrogen peroxide, Glucose oxidaseAbstract
Diabetes mellitus is a chronic medical condition currently affecting 382 million people across the globe, caused due to increased blood glucose levels due to less insulin production or insulin resistance. Subcutaneous insulin administration for diabetes is the only most accepted therapy for maintaining blood glucose levels in diabetic patients. Many patients with advanced type II diabetes mellitus need to regularly monitor their blood glucose level to keep their blood glucose level in the target range. However long-term insulin therapy through an invasive route of administration causes problems with patient compliance and a sudden decrease in blood glucose levels. An artificial closed-loop insulin release system that mimics the glucose-responsive insulin secretion by β-cells of pancreas is one of the ways to overcome the problem faced with the conventional method of insulin administration. Many polymeric formulations showed an improved glucose-responsive release of insulin when incorporated with glucose-responsive catalysts such as glucose oxidase, phenylboronic acid, and glucose binding proteins, the release rate can be controlled by optimizing the concentration of glucose-responsive catalysts. This article is been focused on different mechanisms of glucose-responsive release by incorporation with glucose-responsive catalysts.
Downloads
References
Wang J, Wang Z, Yu J, Kahkoska AR, Buse JB, Gu Z. Glucose-responsive insulin and delivery systems: Innovation and translation. Adv Mater 2020;32:1902004.
Li X, Fu M, Wu J, Zhang C, Deng X, Dhinakar A, et al. pH-sensitive peptide hydrogel for glucose-responsive insulin delivery. Acta Biomater 2017;51:294-303.
Yu J, Qian C, Zhang Y, Cui Z, Zhu Y, Shen Q, et al. Hypoxia and H2O2 dual-sensitive vesicles for enhanced glucose-responsive insulin delivery. Nano Lett 2017;17:733-9.
Yang J, Cao Z. Glucose-responsive insulin release: Analysis of mechanisms, formulations, and evaluation criteria. J Control Release 2017;263:231-9.
Kim MY, Kim J. Chitosan microgels embedded with catalase nanozyme-loaded mesocellular silica foam for glucose-responsive drug delivery. ACS Biomater Sci Eng 2017;3:572-8.
Zhou X, Wu H, Long R, Wang S, Huang H, Xia Y, et al. Oral delivery of insulin with intelligent glucose-responsive switch for blood glucose regulation. J Nanobiotechnol 2020;18:96.
Yu J, Zhang Y, Ye Y, DiSanto R, Sun W, Ranson D, et al. Microneedle-array patches loaded with hypoxia-sensitive vesicles provide fast glucose-responsive insulin delivery. Proc Natl Acad Sci U S A 2015;112:8260-5.
Yu J, Qian C, Zhang Y, Cui Z, Zhu Y, Shen Q, et al. Hypoxia and H2O2 dual-sensitive vesicles for enhanced glucose-responsive insulin delivery. Nano Lett 2017;17:733-9.
Hu X, Yu J, Qian C, Lu Y, Kahkoska AR, Xie Z, et al. H2O2-responsive vesicles integrated with transcutaneous patches for glucose-mediated insulin delivery. ACS Nano 2017;11:613-20.
Tong Z, Zhou J, Zhong J, Tang Q, Lei Z, Luo H, et al. Glucose- and H2O2-responsive polymeric vesicles integrated with microneedle patches for glucose-sensitive transcutaneous delivery of insulin in diabetic rats. ACS Appl Mater Interfaces 2018;10:20014-24.
Liu X, Li C, Lv J, Huang F, An Y, Shi L, et al. Glucose and H2O2 dual-responsive polymeric micelles for the self-regulated release of insulin. ACS Appl Bio Mater 2020;3:1598-606.
Miyata T, Jikihara A, Nakamae K, Hoffman AS. Preparation of poly(2- glucosyloxyethyl methacrylate)-concanavalin A complex hydrogel and its glucose-sensitivity. Macromol Chem Phys 1996;197:1135-46.
Miyata T, Jikihara A, Nakamae K, Hoffman AS. Preparation of reversibly glucose-responsive hydrogels by covalent immobilization of lectin in polymer networks having pendant glucose. J Biomater Sci Polym Ed 2004;15:1085-98.
Available from: https://www.obaidat1996.pdf
Yin R, Wang K, Du S, Chen L, Nie J, Zhang W. Design of genipin-crosslinked microgels from concanavalin A and glucosyloxyethyl acrylated chitosan for glucose-responsive insulin delivery. Carbohydr Polym 2014;103:369-76.
Ye T, Yan S, Hu Y, Ding L, Wu W. Synthesis and volume phase transition of concanavalin A-based glucose-responsive nanogels. Polym Chem 2014;5:186-94.
Zhang R, Tang M, Bowyer A, Eisenthal R, Hubble J. Synthesis and characterization of a d-glucose sensitive hydrogel based on CM-dextran and concanavalin A. React Funct Polym 2006;66:757-67.
Tanna S, Taylor MJ, Sahota TS, Sawicka K. Glucose-responsive UV polymerised dextran-concanavalin A acrylic derivatised mixtures for closed-loop insulin delivery. Biomaterials 2006;27:1586-97.
Taylor MJ, Tanna S, Sahota TS, Voermans B. Rheological characterisation of dextran-concanavalin A mixtures as a basis for a self-regulated drug delivery device. Eur J Pharm Biopharm 2006;62:94-100.
Krug AW, Visser SA, Tsai K, Kandala B, Fancourt C, Thornton B, et al. Clinical evaluation of MK-2640: An insulin analog with glucose-responsive properties. Clin Pharmacol Ther 2019;105:417-25.
Kaarsholm NC, Lin S, Yan L, Kelly T, van Heek M, Mu J, et al. Engineering glucose responsiveness into insulin. Diabetes 2018;67:299-308.
Brownlee M, Cerami A. Glycosylated insulin complexed to concanavalin A. Biochemical basis for a closed-loop insulin delivery system. Diabetes 1983;32:494-504.
Wang J, Yu J, Zhang Y, Kahkoska AR, Wang Z, Fang J, et al. Glucose transporter inhibitor-conjugated insulin mitigates hypoglycemia. Proc Natl Acad Sci U S A 2019;166:10744-8.
Wang C, Ye Y, Sun W, Yu J, Wang J, Lawrence DS, et al. Red blood cells for glucose-responsive insulin delivery. Adv Mater 2017;29:201606617.
Wang J, Wang Z, Yu J, Zhang Y, Zeng Y, Gu Z. A forskolin-conjugated insulin analog targeting endogenous glucose-transporter for glucose-responsive insulin delivery. Biomater Sci 2019;7:4508-13.
Kuivila HG, Keough AH, Soboczenski EJ. Areneboronates from diols and polyols. J Org Chem 1954;19:780-3.
Kataoka K, Miyazaki H, Bunya M, Okano T, Sakurai Y. On-off regulation of insulin-release by totally synthetic polymer gels responding to external glucose concentration. Am Chem Soc Polym Prepr Div Polym Chem 1999;40:301-2.
Matsumoto A, Kurata T, Shiino D, Kataoka K. Swelling and shrinking kinetics of totally synthetic, glucose-responsive polymer gel bearing phenylborate derivative as a glucose-sensing moiety. Macromolecules 2004;37:1502-10.
Matsumoto A, Yoshida R, Kataoka K. Glucose-responsive polymer gel bearing phenylborate derivative as a glucose-sensing moiety operating at the physiological pH. Biomacromolecules 2004;5:1038-45.
Lee YJ, Pruzinsky SA, Braun PV. Glucose-sensitive inverse opal hydrogels: Analysis of optical diffraction response. Langmuir 2004;20:3096-106.
Zhang Y, Wang J, Yu J, Wen D, Kahkoska AR, Lu Y, et al. Bioresponsive microneedles with a sheath structure for H2O2 and pH cascade‐triggered insulin delivery. Small 2018;14:1704181.
Yu J, Zhang Y, Wang J, Wen D, Kahkoska AR, Buse JB, et al. Glucose-responsive oral insulin delivery for postprandial glycemic regulation. Nano Res 2019;12:1539-45.
Li C, Liu X, Liu Y, Huang F, Wu G, Liu Y, et al. Glucose and H 2 O 2 dual-sensitive nanogels for enhanced glucose-responsive insulin delivery. Nanoscale 2019;11:9163-75.
Zhang C, Hong S, Liu MD, Yu WY, Zhang MK, Zhang L, et al. pH-sensitive MOF integrated with glucose oxidase for glucose-responsive insulin delivery. J Control Release 2020;320:159-67.
Li X, Fu M, Wu J, Zhang C, Deng X, Dhinakar A, et al. pH-sensitive peptide hydrogel for glucose-responsive insulin delivery. Acta Biomater 2017;51:294-303.
Di J, Yu J, Ye Y, Ranson D, Jindal A, Gu Z. Engineering synthetic insulin-secreting cells using hyaluronic acid microgels integrated with glucose-responsive nanoparticles. Cell Mol Bioeng 2015;8:445-54.
Zuo M, Qian W, Xu Z, Shao W, Hu XY, Zhang D, et al. Multiresponsive supramolecular theranostic nanoplatform based on pillar [5] arene and diphenylboronic acid derivatives for integrated glucose sensing and insulin delivery. Small 2018;14:1801942.
Yu J, Qian C, Zhang Y, Cui Z, Zhu Y, Shen Q, et al. Hypoxia and H2O2 dual-sensitive vesicles for enhanced glucose-responsive insulin delivery. Nano Lett 2017;17:733-9.
Mohammadpour F, Hadizadeh F, Tafaghodi M, Sadri K, Mohammadpour AH, Kalani MR, et al. Preparation, in vitro and in vivo evaluation of PLGA/Chitosan based nano-complex as a novel insulin delivery formulation. Int J Pharm 2019;572:118710.
Chu MK, Chen J, Gordijo CR, Chiang S, Ivovic A, Koulajian K, et al. In vitro and in vivo testing of glucose-responsive insulin-delivery microdevices in diabetic rats. Lab Chip 2012;12:2533-9.
Yu J, Zhang Y, Ye Y, DiSanto R, Sun W, Ranson D, et al. Microneedle-array patches loaded with hypoxia-sensitive vesicles provide fast glucose-responsive insulin delivery. Proc Natl Acad Sci U S A 2015;112:8260-5.
Fu Y, Liu W, Wang LY, Zhu BY, Qu MK, Yang LQ, et al. Erythrocyte‐membrane‐camouflaged nanoplatform for intravenous glucose‐responsive insulin delivery. Adv Function Mater 2018;28:1802250.
Gu Z, Dang TT, Ma M, Tang BC, Cheng H, Jiang S, et al. Glucose-responsive microgels integrated with enzyme nanocapsules for closed-loop insulin delivery. ACS Nano 2013;7:6758-66.
Gordijo CR, Shuhendler AJ, Wu XY. Glucose‐responsive bioinorganic nanohybrid membrane for self‐regulated insulin release. Adv Function Mater 2010;20:1404-12.
Chu MK, Gordijo CR, Li J, Abbasi AZ, Giacca A, Plettenburg O, et al. In vivo performance and biocompatibility of a subcutaneous implant for real-time glucose-responsive insulin delivery. Diabetes Technol Ther 2015;17:255-67.
Jo SM, Lee HY, Kim JC. Glucose-sensitivity of liposomes incorporating conjugates of glucose oxidase and poly N-isopropylacrylamide-co-methacrylic acid-co-octadecylacrylate. Int J Biol Macromol 2009;45:421-6.
Li X, Shang H, Wu W, Li S, Lin Z, Duan J, et al. Glucose-responsive micelles for controlled insulin release based on transformation from amphiphilic to double hydrophilic. J Nanosci Nanotechnol 2016;16:5457-63.
Zhang Y, Wang J, Yu J, Wen D, Kahkoska AR, Lu Y, et al. Bioresponsive microneedles with a sheath structure for H2O2 and pH cascade‐triggered insulin delivery. Small 2018;14:1704181.
Jamwal S, Ram B, Ranote S, Dharela R, Chauhan GS. New glucose oxidase-immobilized stimuli-responsive dextran nanoparticles for insulin delivery. Int J Biol Macromol 2019;123:968-78.
Oroval M, Díez P, Aznar E, Coll C, Marcos MD, Sancenón F, et al. Self‐regulated glucose‐sensitive neoglycoenzyme‐capped mesoporous silica nanoparticles for insulin delivery. Chem Eur J 2017;23:1353-60.
Agazzi M, Herrera S, Cortez ML, Marmisollé W, Tagliazucchi M, Azzaroni O. Insulin‐delivery from glucose‐responsive self‐assembled polyamine nanoparticles: Smart “Sense‐and‐Treat” nanocarriers made easy. Chem Eur J 2019;26:2456-63.
Baena-Díez JM, Peñafiel J, Subirana I, Ramos R, Elosua R, Marín- Ibañez A, et al. Risk of cause-specific death in individuals with diabetes: A competing risks analysis. Diabetes Care 2016;39:1987-95.
Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010;87:4-14.
Guariguata L, Linnenkamp U, Beagley J, Whiting DR, Cho NH. Global estimates of the prevalence of hyperglycaemia in pregnancy. Diabetes Res Clin Pract 2014;103:176-85.
Blas E, Kurup AS, editors. Equity, Social Determinants and Public Health Programmes. Geneva: World Health Organization; 2010.
International Diabetes Federation. IDF Diabetes Atlas. 7th ed. Brussels, Belgium: International Diabetes Federation; 2015. Available from: http://www.diabetesatlas.org
Brown AF, Ettner SL, Piette J, Weinberger M, Gregg E, Shapiro MF, et al. Socioeconomic position and health among persons with diabetes mellitus: A conceptual framework and review of the literature. Epidemiol Rev 2004;26:63-77.
Shen D, Yu H, Wang L, Khan A, Haq F, Chen X, et al. Recent progress in design and preparation of glucose-responsive insulin delivery systems. J Control Release 2020;321:236-58.
Zhang Y, Wang J, Yu J, Wen D, Kahkoska AR, Lu Y, et al. Bioresponsive microneedles with a sheath structure for H2O2 and pH cascade‐triggered insulin delivery. Small 2018;14:1704181.
Yin R, Wang K, Du S, Chen L, Nie J, Zhang W. Design of genipin-crosslinked microgels from concanavalin A and glucosyloxyethyl acrylated chitosan for glucose-responsive insulin delivery. Carbohydr Polym 2014;103:369-76.
Chang R, Li M, Ge S, Yang J, Sun Q, Xiong L. Glucose-responsive biopolymer nanoparticles prepared by co-assembly of concanavalin A and amylopectin for insulin delivery. Ind Crops Prod 2018;112:98-104.
Yin R, Tong Z, Yang D, Nie J. Glucose and pH dual-responsive concanavalin a based microhydrogels for insulin delivery. Int J Biol Macromol 2011;49:1137-42.
Lee D, Choe K, Jeong Y, Yoo J, Lee SM, Park JH, et al. Establishment of a controlled insulin delivery system using a glucose-responsive double-layered nanogel. RSC Adv 2015;5:14482-91.
Yin R, Han J, Zhang J, Nie J. Glucose-responsive composite microparticles based on chitosan, concanavalin A and dextran for insulin delivery. Colloids Surf B Biointerfaces 2010;76:483-8.
Bai M, He J, Kang L, Nie J, Yin R. Regulated basal and bolus insulin release from glucose-responsive core-shell microspheres based on concanavalin A-sugar affinity. Int J Biol Macromol 2018;113:889-99.
Yin R, Wang K, Han J, Nie J. Photo-crosslinked glucose-sensitive hydrogels based on methacrylate modified dextran-concanavalin A and PEG dimethacrylate. Carbohydr Polym 2010;82:412-8.
Faria A, Persaud SJ. Cardiac oxidative stress in diabetes: Mechanisms and therapeutic potential. Pharmacol Ther 2017;172:50-62.
Fox CS, Coady S, Sorlie PD, D’Agostino RB, Pencina MJ, Vasan RS, et al. Increasing cardiovascular disease burden due to diabetes mellitus: The Framingham heart study. Circulation 2007;115:1544-50.
Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-53.
Mo R, Jiang T, Di J, Tai W, Gu Z. Emerging micro-and nanotechnology based synthetic approaches for insulin delivery. Chem Soc Rev 2014;43:3595-629.
Goldberg M, Gomez-Orellana I. Challenges for the oral delivery of macromolecules. Nat Rev Drug Discov 2003;2:289-95.
Mitragotri S, Burke PA, Langer R. Overcoming the challenges in administering biopharmaceuticals: Formulation and delivery strategies. Nat Rev Drug Discov 2014;13:655-72.
Porte D, Pupo AA. Insulin responses to glucose: Evidence for a two pool system in man. J Clin Investig 1969;48:2309-19.
Zhu Y, Tong W, Gao C. Molecular-engineered polymeric microcapsules assembled from Concanavalin A and glycogen with specific responses to carbohydrates. Soft Matter 2011;7:5805-15.
Wang J, Wang Z, Yu J, Kahkoska AR, Buse JB, Gu Z. Glucose-responsive insulin and delivery systems: Innovation and translation. Adv Mater 2020;32:1902004.
Huang Q, Wang L, Yu H, Ur-Rahman K. Advances in phenylboronic acid-based closed-loop smart drug delivery system for diabetic therapy. J Control Release 2019;305:50-64.
Brooks WL, Deng CC, Sumerlin BS. Structure-reactivity relationships in boronic acid-diol complexation. ACS Omega 2018;3:17863-70.
Matsumoto A, Ikeda S, Harada A, Kataoka K. Glucose-responsive polymer bearing a novel phenylborate derivative as a glucose-sensing moiety operating at physiological pH conditions. Biomacromolecules 2003;4:1410-6.
Matsumoto A, Ishii T, Nishida J, Matsumoto H, Kataoka K, Miyahara Y. A synthetic approach toward a self-regulated insulin delivery system. Angew Chem Int Ed 2012;51:2124-8.
Mcdaniel D, Brown HC. An extended table of Hammett Substitutent constants based on the ionization of substituted benzoic acids. J Organomet Chem 1958;23:420-7.
Guo X, Wang W. Challenges and recent advances in the subcutaneous delivery of insulin. Expert Opin Drug Deliv 2017;14:727-34.
Chen X, Wang L, Yu H, Li C, Feng J, Haq F, et al. Preparation, properties and challenges of the microneedles-based insulin delivery system. J Control Release 2018;288:173-88.
Owens DR, Bolli GB, Zinman B. Alternative routes of insulin delivery. In: International Textbook of Diabetes Mellitus. United States: Wiley; 2003.
Wu Q, Wang L, Yu H, Wang J, Chen Z. Organization of glucose-responsive systems and their properties. Chem Rev 2011;111:7855-75.
Huang Q, Wang L, Yu H, Ur-Rahman K. Advances in phenylboronic acid-based closed-loop smart drug delivery system for diabetic therapy. J Control Release 2019;305:50-64.
Keilin D, Hartree EF. Properties of glucose oxidase (notatin) Addendum. Sedimentation and diffusion of glucose oxidase (notatin). Biochem J 1948;42:221-9.
Goodsell DS. Glucose oxidase. In: Molecule of the Month: PCSB Protein Data Bank. United States: PCSB Bank; 2006.
Xu X, Shang H, Zhang T, Shu P, Liu Y, Xie J, et al. A stimuli-responsive insulin delivery system based on reversible phenylboronate modified cyclodextrin with glucose triggered host-guest interaction. Int J Pharm 2018;548:649-58.
Chou DH, Webber MJ, Tang BC, Lin AB, Thapa LS, Deng D, et al. Glucose-responsive insulin activity by covalent modification with aliphatic phenylboronic acid conjugates. Proc Natl Acad Sci 2015;112:2401-6.
Seki T, Abe K, Egawa Y, Miki R, Juni K, Seki T. A pseudopolyrotaxane for glucose-responsive insulin release: The effect of binding ability and spatial arrangement of phenylboronic acid group. Mol Pharm 2016;13:3807-15.
Wang J, Yu J, Zhang Y, Zhang X, Kahkoska AR, Chen G, et al. Charge-switchable polymeric complex for glucose-responsive insulin delivery in mice and pigs. Sci Adv 2019;5:eaaw4357.
Published
How to Cite
Issue
Section
Copyright (c) 2021 Saurabh sharma, Ashutosh Kashyap, Prasanta kumar Biswal, Dr Surya Narayan Das
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
